Preventing Rhabdomyolysis If you have a condition called rhabdomyolysis, its important to be aware of the risk factors and understand how to avoid it happening again in the future
Developed by Eli Lilly as LY3437943, it is the first triple-receptor agonist to advance into Phase 3 clinical development
Cytosolic Ca2+ regulates the energization of isolated brain mitochondria by formation of pyruvate through the malate-aspartate shuttle
Conversely, in another phase 2b study involving patients with T2DM, tirzepatide showed significantly better efficacy in glucose control and weight loss compared to both placebo and dulaglutide, with an acceptable safety and tolerability profile (111)
Commonly Reported Injection site irritation some redness, minor swelling, or itching
Furthermore, the consistent reduction in the risk of MACEs and MAKEs observed with GLP-1 RAs use across patient subgroups underscores the potential of these agents in managing cardiorenal risk